[Federal Register Volume 84, Number 194 (Monday, October 7, 2019)]
[Notices]
[Page 53448]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-21784]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-3500]


Fit for Use Pilot Program Invitation for the Clinical Data 
Interchange Standards Consortium for Standard for Exchange of 
Nonclinical Data Implementation Guide: Version 3.1; Correction

AGENCY: Food and Drug Administration, HHS.

ACTION: Correction.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is correcting a notice 
that appeared in the Federal Register of Tuesday, August 20, 2019. The 
document announced a ``Fit for Use Pilot Program Invitation for the 
Clinical Data Interchange Standards Consortium for Standard for 
Exchange of Nonclinical Data Implementation Guide: Version 3.1.'' The 
document was published with the incorrect contact name, phone number, 
and email address in the FOR FURTHER INFORMATION CONTACT section. This 
document corrects those errors.

FOR FURTHER INFORMATION CONTACT: Jesse Anderson, Office of 
Computational Science, Center for Drug Evaluation and Research, Food 
and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 
20993, 301-348-1816, Jesse.Anderson@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: In FR Doc. 2019-17877, appearing on page 
43139, in the Federal Register of Tuesday, August 20, 2019 (84 FR 
43139), the following correction is made:
    On page 43140, in the first column, in the FOR FURTHER INFORMATION 
CONTACT section of the document, ``Isaac Chang, Office of Computational 
Science, Center for Drug Evaluation and Research, Food and Drug 
Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993, 240-
4027501, PRAStaff@fda.hhs.gov.'' is corrected to read ``Jesse Anderson, 
Office of Computational Science, Center for Drug Evaluation and 
Research, Food and Drug Administration, 10903 New Hampshire Ave., 
Silver Spring, MD 20993, 301-348-1816, Jesse.Anderson@fda.hhs.gov.''

    Dated: September 30, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-21784 Filed 10-4-19; 8:45 am]
 BILLING CODE 4164-01-P


